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Background 
Reoperative thyroid surgery is relatively rare, but still 
represents a major challenge, even for skilled surgeons, 
because of the higher incidence of complications 
than in primary thyroid operations,  in particular 
hypoparathyroidism and injury to the recurrent laryngeal 
nerve (RLN). The RLN is at high risk during reoperations, 
due to the likelihood of displacement and scarring following 
previous neck surgery. The prevalence of RLN injury 
during reoperative thyroid surgery is as high as 12.5% for 
transient injury and up to 3.8% for permanent injury, which 
is a serious complication influencing the quality of life and 
having a wide range of symptoms (1-15) (Table 1).
The indications for reoperative surgery for thyroid 
disease vary, and the patients for this type of procedure 
are not a homogenous group (11,16-19). It is sometimes 
indicated for nodular recurrence after partial surgery 
for initially benign thyroid disease, mainly after bilateral 
subtotal thyroidectomy, or to complete total thyroidectomy 
when thyroid cancer is recognized in histopathological 
report after the thyroid gland is partially removed in the 
initial operation. Secondary thyroidectomies also include 
the completion thyroidectomy following a lobectomy 
for differentiated thyroid carcinoma, or for contralateral 
recurrent goiter after a previous hemithyroidectomy. In this 
kind of redo surgery it is generally easier for the surgeon 
to remove all the remaining tissue than after subtotal 
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thyroid resection, which can leave behind extensive local 
scarring. Nowadays reoperative thyroid surgery is an 
uncommon procedure, because of the growing acceptance 
of total thyroid operations for benign multinodular goiter 
(BMNG) in the last two decades (20-22). This trend is in 
accordance with recommendations from the British and 
American Thyroid Associations, which suggest avoiding 
subtotal procedures for BMNG in favour of a hemi- or total 
thyroidectomy during the initial procedure (23). 
Routine identification of the RLN has been the gold 
standard in thyroid surgery for three decades, and is the 
best way to prevent inadvertent injury and to minimize 
the rate of postoperative vocal cord palsy (24-28). In 
recent years intraoperative neuromonitoring (IONM) has 
gained more acceptances among endocrine surgeons and 
laryngologists as an adjunct to visual RLN identification 
(29-32). IONM of the RLN and the external branch of the 
superior laryngeal nerve (EBSLN) have been standardized 
and seem to be beneficial in high risk thyroid operations, 
particularly in reoperations (25,26). In recent years there 
have been many publications concerning the introduction 
of IONM, the learning curve and the technical aspects 
of new the technology, and assessing the prevalence of 
complications when utilizing IONM (17,20,25-27,29-32). 
But very little data concerning the incidence of RLN injury 
in reoperations with IONM has been published, and only a 
few publications have compared the RLN injury rate during 
secondary thyroid surgery using IONM with procedures 
using only visual RLN identification (16-19,33,34). 
The aim of this study was to evaluate the use of 
intermittent IONM of the RLN in surgery for recurrent 
goiter. We focused not only on the final effect of IONM 
in reoperations, but also on practical aspects such as RLN 
identification in a scarred operative field and surgical 
strategy in reoperations. 
IONM in recurrent goiter
In 1938, Lahey showed that careful dissection of the RLN 
does not increase the rate of RLN injury during thyroid 
operations; instead, it significantly reduces the frequency 
of RLN palsy (35). This study launched a new approach to 
thyroid surgery. In the following years many publications 
confirmed those findings (20,24,36,37). The largest study 
was conducted by Jatzko et al., involving 12,211 thyroid 
operations, and it confirmed that the prevalence of 
transient and permanent paresis in operations where the 
RLN was not visualized (7.9% and 5.2%, respectively) 
was significantly higher than in operations in which the 
nerve was visualized (2.7% and 1.2%, respectively) (24). 
For many years the RLN was visualized using various 
different techniques, including the use of magnifying glasses 
Table 1 Articles on reoperative thyroid surgery published in English-language publications
Author Year Patients (n) NAR (n) Temporary RLN injury (%) Permanent RLN palsy (%)
Reeve et al. (1) 1988 408 ND 6 (1.5)* ND
Levin et al. (2) 1992 114 ND 1 (0.9)* 1 (0.9)*
Seiler et al. (3) 1996 166 242 ND 10 (4.1)
Chao et al. (4) 1997 115 ND 3 (2.6)* 2 (1.7)*
Peix et al. (5) 1997 47 ND 2 (4.2)* 0 (0)*
Makeieff et al. (6) 1998 117 ND 3 (2.5)* 2 (1.7)*
Wilson et al. (7) 1998 32 ND 2 (6.2)* 1 (3.1)*
Menegaux et al. (8) 1999 202 ND 5 (2.5)* 2 (1.0)*
Müller et al. (9) 2001 949 1,307 46 (3.5) 33 (2.5)
Gibelin et al. (10) 2004 122 ND 15 (12.3)* 1 (0.8)*
Lefevre et al. (11) 2007 685 ND 8 (1.2)* 10 (1.5)*
Calò et al. (12) 2012 106 174 5 (2.9) 1 (0.6)
Kurmann et al. (13) 2012 109 133 ipsilateral; 33 contralateral ND; ND 5 (3.8); 0 (0)
Hardman et al. (14) 2015 164 ND 9 (5.5)* 3 (1.8)*
Miccoli et al. (15) 2015 214 ND 7 (3.3) * 1 (0.4)*
*, calculation for patients, not for NAR. ND, no data; NAR, nerve at risk; RLN, recurrent laryngeal nerve.
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(21,23,24,36,37). Since Shedd’s introduction of IONM 
in thyroid surgery in 1966, identification of the RLN 
has been much easier, which has reduced postoperative 
complications (38). In the first randomized prospective 
study of 1,000 patients undergoing thyroid reoperation 
for recurrent goiter, Barczyński et al. showed that the 
prevalence of transient RLN palsy was significantly lower 
among patients whose surgery utilized IONM (2.9% 
lower in high risk patients and 0.9% lower in low-risk 
patients) than among those whose operations involved only 
RLN visualization (39). Reoperations are undoubtedly 
more dangerous for the RLN than primary operations 
(11,12,14,15), hence the utilization of IONM should be 
always recommended to minimize the risk of nerve injury 
due to certain advantages the technique has over visual 
identification alone. 
RLN identification and mapping 
The rate of RLN identification with IONM is near 100%, 
because neuromonitoring can locate the RLN before 
visual confirmation (40,41). The nerve is mapped out in 
the paratracheal region through probe stimulation and 
then visually identified through directed dissection based 
on the neural mapping (25). This technique is particularly 
beneficial in reoperations where there is scar tissue from the 
first thyroid operation. Barczyński et al. showed that almost 
20% of the RLNs were identified with IONM before visual 
exposition of the nerve, and almost twice as many ramified 
nerves were identified in reoperations with IONM than 
without monitoring (P<0.001) (17). Moreover, the use 
of IONM significantly (P=0.02) improved identification 
of non-recurrent laryngeal nerves (non-RLNs) than in 
operations without monitoring (17).
In a scarred operating field there can be problems with 
hemostasis because of the high degree of vascularization. 
In these cases, mapping the RLN through the overlying 
tissue can minimize bleeding during reoperations (11,12,14). 
IONM is helpful in distinguishing branches of the RLN 
from the vessels and scarred tissue (42,43). When the 
nerve is imbedded in a scar, IONM should be used first for 
mapping and identification and then for monitoring during 
dissection (44-47). 
Mapping the RLN is especially helpful in reoperations 
where the nerve is distorted in any direction, which can 
disorient surgeons and could lead to inadvertent injury if 
the nerve is mistaken for other structures (non-anatomical 
courses of the nerve are described later in the text). When 
mapping the RLN in a scarred field, 2 mA stimulation is 
recommended. For confirmation of the RLN or further 
intraoperative monitoring we use 1 mA. In cases where two 
similar structures are close together, lower stimulations (for 
example 0.5 mA) can be used to distinguish them (47,48). 
The RLN in reoperative thyroid surgery
The RLN is prone to injury during thyroid surgery because 
it has a wide range of anatomical variants, and may be in 
various positions relative to the inferior thyroid artery. In 
about 50% of cases the nerve branches, and in 0.03% the 
non-RLN could be present (16-19,33,34,49). Other risk 
factors involved in RLN injury are hyperthyroidism, the 
extent of the surgical treatment and of course the surgeon’s 
experience with endocrine surgery (11,14). However, 
reoperations seem to be the major risk factor for nerve 
injury. As we have already stated, in thyroid reoperations 
the RLN may be displaced in any direction (44-47). Usually 
we find the nerve adherent to the lateral capsule of the 
remnant thyroid mass or adherent strictly to the inferior 
part of a recurrent goiter. Another obstacle in reoperations 
is (as noted earlier) massive scarring after the first operation, 
in which the nerve could be imbedded (16-19,33,34). A 
scarred operating field, in particular after subtotal thyroid 
operations, makes it difficult not only to find the RLN but 
also to separate it from other structures.
The RLN adherent to the lateral capsule of a goiter in 
reoperation
RLNs adherent to the lateral capsule of a goiter are most 
frequently seen in huge retrosternal recurrent goiters, many 
years after the first partially removed goiter (Figure 1). 
The nerve is dislocated from its typical course due to 
the remnant thyroid tissue growing close to it. There 
is a high risk of RLN dislocation when Zuckerkandl’s 
tubercle was missed in the first thyroid operation (50). 
In initial thyroidectomies the RLN always runs under 
Zuckerkandl’s tubercle, but in reoperations the RLN 
could be adherent to the lateral capsule of this tubercle. 
This leaves the nerve at great risk of inadvertent injury, 
because it is usually is almost invisible, in particular at the 
beginning of the operation. In such a position, the nerve 
may be mistaken for other structures, such as fibrosis or 
blood vessels, and transected inadvertently (33,44,45,50). 
Clamping or transecting any structure before careful 
preparation of the thyroid tissue and identification of the 
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nerve should be avoided (25,33,47). Visual identification 
of the RLN in cases where the nerve is imbedded in the 
capsule of a goiter is very difficult and sometimes even 
skilled surgeons have difficulty in finding it. IONM, 
in particular mapping the nerve at the beginning of 
the reoperation, is recommended. By using IONM not 
only are we able to identify the nerve, but we can also 
separate the nerve from the goiter (46). When the nerve 
is dissected completely from the remaining thyroid tissue, 
the functional integrity of the nerve should be confirmed 
with IONM in accordance with the IONM Study Group 
recommendations (25). This final confirmation of RLN 
functionality is crucial in cases where the RLN runs over 
a huge goiter, because the nerve is particularly prone 
to overstretching with potential loss of function after 
dissection.
A potential non-anatomical RLN course like this shows 
that the lateral approach seems to be the most useful 
technique in repeat thyroid operations, since it allows the 
surgeons to reach the remnant tissue through a previously 
undisturbed plane (25). 
The RLN attached to the inferior part of a goiter in 
reoperation
This non-typical course of the nerve is seldom seem 
in primary thyroid operations, but should be always 
considered in retrosternal or mediastinal enlargements in 
reoperations. A huge goiter could also be involved in this 
type of dislocation (14,44,51). The remnant retrosternal 
thyroid mass, often missed during the first procedure, 
subsequently grows, moving the nerve to the inferior part 
of the goiter (Figure 2). Pulling the thyroid mass out of the 
mediastinum at the beginning of the operation is likely to 
overstretch the RLN imbedded in the inferior part of the 
goiter. In retrosternal goiters, extensive traction from the 
mediastinum should be avoided until the goiter is mobilized 
(52,53). All structures adherent to the inferior part of the 
goiter should be mapped using IONM. In retrosternal 
redo surgery, an inferior approach to the RLN seems 
optimal (44). Once identified, the RLN should be followed 
throughout its course and freed from the scar tissue under 
IONM guidance, with postoperative confirmation of RLN 
functionality (25).
The RLN embedded in a scar in reoperation
Scarring from the first intervention is the main obstacle 
during reoperations (16-19,33,34) (Figure 3). As we have 
pointed out, it makes it difficult to identify and to dissect 
the RLN, and the operating field is much more prone for 
bleeding than in first intervention. Visual identification 
of the RLN may be difficult or even impossible by 
inexperienced personnel. Extensive scarring is usually 
seen shortly after primary thyroid operations, in particular 
when completing a total thyroidectomy in cases of thyroid 
Figure 1 The RLN adherent to the lateral capsule of a goiter in 
reoperative thyroid surgery. RLN, recurrent laryngeal nerve.
Figure 2 The RLN adherent to the inferior part of a goiter in 
reoperative thyroid surgery. RLN, recurrent laryngeal nerve.
Figure 3 The RLN imbedded in a scar. RLN, recurrent laryngeal 
nerve.
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cancer. Even when the scarring from the first operation is 
so massive that it is not possible to isolate the nerve, using 
IONM to map the outline of the nerve before any cutting 
can help the surgical team remove most of the remnant 
tissue around the nerve while minimizing damage to the 
nerve itself (16-19,33,34).
The extent of surgery in thyroid reoperations 
with IONM 
Total thyroidectomy is recommended by many guidelines in 
both benign and malignant disorders (20,53,54). In recent 
years, we see fewer partial resections in cases of benign 
goiter, so the number of recurrent goiters is lower. The 
completeness of a total thyroidectomy needs to be ensured, 
not only because it can improve oncological outcomes in 
cancer patients, but also because each subsequent operation 
is associated with a higher incidence of nerve injury (14). 
After the first partial thyroid operation, the remnant 
tissue is usually close to Berry’s ligament or Zuckerkandl’s 
tubercle, where the RLN is at high risk of injury (40,50,53). 
The RLN is most commonly injured in the last 2 cm 
before entering the larynx (53,55). Neuromonitoring helps 
the surgeon achieve optimal exposure of the RLN in this 
region, making it possible to perform complete and secure 
resection in this difficult region (19).
In two groups of patients who underwent thyroid 
reoperations with or without IONM, the number of total 
thyroidectomies was higher in monitored operations (38% 
vs. 19.5% in procedures without IONM) (16). Similarly, 
in a study about thyroid reoperations by Barczytal 
thyroidectomies was higher in monitored operations (38% 
vs. 19.5% in procedures without IONM) (16). Similarly, in 
a study about thyroid reoperations by Barczyński et al., total 
thyroidectomies were performed significantly more often 
with IONM: 58.2% as opposed to 25.1% with only visual 
RLN identification (17). 
Surgical strategy with IONM 
Neuromonitoring should be carried out in accordance 
with the recommendations of the International Neural 
Monitoring Study Group (25,26). 
The use of intermittent IONM allows the functionality 
of the RLN to be tested during surgery (25,44,47). 
Anatomical intactness of the nerve does not mean that the 
function of the nerve is preserved. In case of a decrease 
in amplitude by more than 30–50% from the baseline, 
surgeons can stop the procedure, reduce the traction and 
continue dissection after spontaneous EMG signal recovery. 
Electric vagal nerve testing at the end of the procedure 
provides information about nerve functionality, which can 
influence surgical strategy as the operation proceeds. In case 
of a loss of signal on the dominant side of the neck operated 
on first, a staged thyroidectomy should be considered 
in order to prevent bilateral nerve injuries. Staged 
thyroidectomies are gaining acceptance among surgeons, 
particularly in redo surgery (56,57).
The prevalence of RLN injury in reoperations 
with IONM
Despite lacking hard evidence that IONM can diminish 
prevalence of permanent vocal fold’s palsy as many as 95.7% 
of the respondents of the most recent international survey 
on the identification and neural monitoring of the EBSLN 
during thyroidectomy expressed their confidence in IONM 
and listed reoperative thyroid cases as the top indication 
far ahead all other clinical situations for utilization of this 
technique during thyroid surgery (58). There are only a 
few publications concerning the prevalence of RLN injury 
in reoperations with IONM, or comparing reoperations 
performed with or without IONM (16-19,33,34). Moreover, 
the power of the data are not sufficient to validate the 
differences, because of the small number of patients under 
consideration. Another problem is the lack of homogeneity 
among patients undergoing thyroid reoperations. There 
are different indications for reoperations; the extent of 
surgery ranges from lobectomy to the completion of a total 
resection; and the experience of the surgeons performing 
the operations are different as well. The prevalence of 
RLN injury during reoperations as reported in the available 
literature is shown in Table 2.
In a major retrospective cohort study from 2014, 
Barczyński et al. compared reoperations with and without 
IONM, and found that intraoperative neuromonitoring can 
reduce the prevalence of recurrent laryngeal nerve injury 
in thyroid reoperations (P=0.001). The study included 854 
patients (1,326 RLNs at risk), and transient and permanent 
RLN injuries were found respectively in 13 (2.6%) and 7 
(1.4%) nerves with IONM, as opposed to 52 (6.3%) and 20 
(2.4%) nerves without IONM (BAR). IONM significantly 
decreased the incidence of transient RLN paresis compared 
with visualization alone (P=0.003); the prevalence of 
permanent RLN injury was also lower with IONM, but the 
difference was not statistically significant (P=0.202) (17). In 
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Table 2 Articles on reoperative thyroid surgery with IONM vs. without IONM in English-language publications
Author Year
Patients/NAR (n) Temporary RLN injury Permanent RLN palsy
With IONM Without IONM
With IONM 
(%)
Without IONM 
(%)
P value
With IONM 
(%)
Without IONM 
(%)
P value
Yarbrough et al. (34) 2004 52 59 ND ND ND 1 (1.90) 1 (1.7) ND
Alesina et al. (16) 2012 89/128 157/161 8 (6.2) 4 (2.5) 0.100 0 1 (0.6)* 1.0000
Chuang and Huang (33) 2013 56/70 15/15 0 0 – 1 (1.43) 3 (20.0) 0.0164
Barczyński et al. (17) 2014 306/500 826/548 13 (2.6) 52 (6.3) 0.003 7 (1.40) 20 (2.4) 0.2020
Hei et al. (18) 2016 33/41 37/43 5 (12.2) 3 (7.0) 0.625 2 (4.90) 1 (2.3) 0.9660
Salari et al. (19) 2016 181 – 0 – – 0 – –
*, preoperative unilateral palsy. IONM, intraoperative neuromonitoring; ND, no data; NAR, nerve at risk; RLN, recurrent laryngeal nerve.
7.5% of the patients who underwent reoperations, staged 
thyroidectomy was performed due to intraoperative loss of 
signal. No bilateral RLN palsy was observed in the group 
with IONM. In one patient bilateral palsy was observed 
in the group that underwent reoperation with only RLN 
visualization, but unilateral palsy was observed after the first 
operation. It is worth emphasizing that in reoperations both 
the negative predictive value (NPV) and positive predictive 
value (PPV) of IONM were high: 99.6% and 78.3% 
respectively (17). 
Chuang and Huang recommended the routine use of 
IONM in thyroid and parathyroid reoperations because the 
rate of RLN injury with IONM was 1.43%, as opposed to 
20% without monitoring (P=0.0164) (33).
The results reported by Barczyński et al. and by Chuang 
and Huang differ from findings published earlier. In 2004, 
Yarbrough et al. considered 52 cervical reexploration 
procedures, and showed that intraoperative monitoring 
of the RLN in reoperative neck surgery can be performed 
safely, but did not decrease RLN complications. In that 
study, there was a similar rate of complications in both 
groups: 1.9% with IONM vs. 1.7% without IONM. 
Yarbrough et al. concluded that thyroid reexplorations 
could be performed safely, but experience and routine 
nerve exposure remain crucial to the minimization of RLN 
complications (34). Similarly, Alesina et al. did not observe 
significant differences in the prevalence of RLN injuries 
between 91 operations with IONM and 159 procedures 
with direct nerve visualization (16). The overall incidence 
of postoperative transient nerve palsy was 4.1%, and it 
was not significantly different between the groups (P=0.1). 
However, this study was influenced by selection bias, as the 
decision to use IONM was dependent on the availability 
of the equipment and the individual surgeon’s preferences 
considering the planned extent of the surgical procedure. In 
the neuromonitoring group, there were twice as many total 
thyroid operations, which is an additional risk factor for 
complications (16). Moreover, the studies by Yarbrough et al. 
and Alesina et al. were both based on relatively small groups 
of patients, and statistical validation of small differences in 
the prevalence of RLN injury require more RLNs at risk. 
The next  study we found regarding the use of 
intermittent IONM in thyroid reoperations was from 
2015 (18). It was a small randomized single-surgeon 
study involving 70 patients; 33 of them (41 RLNs at risk) 
underwent reoperations with IONM, and 37 (43 RLNs 
at risk) were enrolled in the control group, who were 
operated on without IONM. In the IONM group the 
incidence of temporary RLN paralysis was 12.2%, and the 
rate of permanent RLN paralysis was 4.9%, compared with 
7.0% and 2.3% in the control group (P=0.658, P=0.966, 
respectively) (18). The limitations of this study were the 
small sample and the fact that it was a single-surgeon study. 
In 2015, the Laryngoscope published an interesting 
review article by Salari et al. about the use of IONM in 
recurrent thyroid cancer. The study involved 181 patients 
undergoing reoperation for local recurrent thyroid 
cancer, all performed by the same surgeon and all using 
IONM. Fourteen percent of the patients presented 
with permanent vocal cord paresis (VCP) after the first 
operation. Interestingly, none developed temporary or 
permanent VCP after the thyroid reoperation. Salari et al. 
pointed out that techniques such as IONM allow the 
identification of the vagus nerve at the initial phase of 
surgery, and the identification of the RLN inferiorly in the 
tracheoesophageal groove can help reduce the morbidity 
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of central compartment dissections. The study also 
demonstrated that neuromonitored reoperative thyroid 
surgery in a large cohort of papillary thyroid cancer patients 
is effective, with a robust response in thyroglobulin (in this 
study the sTG level was undetectable in 58% of the PTC 
patients postoperatively), while at the same time it is safe, 
with a low rate of complications, even among the 14% of 
the patients who had unilateral palsy before surgery (19).
Conclusions 
Extensive knowledge of RLN anatomy, routine visual 
RLN identification, experience and training are standard 
requirements for RLN management during thyroidectomy 
(42,44,46,47). But in reoperative thyroid surgery, even 
experienced surgeons can have difficulty in identifying the 
nerve and dissecting it from scar tissue (11,12,14,16-19,33). 
Whether intermittent IONM can provide additional 
benefits in thyroid reoperations is still controversial among 
surgeons (16,17). If we asses only the prevalence of RLN 
injury in reoperations with or without IONM, the results 
differ from study to study. On the other hand, in each of 
the publications mentioned in this review we found that 
IONM provides more information about RLN anatomy 
and its branches, and helped predict postoperative RLN 
function. In all the studies, the value of IONM in dissecting 
the RLN from scar tissue or mapping a distorted nerve is 
emphasized.
One problem in evaluating redo surgery with IONM is 
the fact that most of the articles have some limitations: small 
groups of patients, differences in the amount of experience 
the surgeons have, different operating techniques; and 
we found only one randomized study. In the future, 
multicenter prospective studies with large sample sizes are 
needed to further assess the role of intermittent IONM in 
thyroid reoperations. Despite lacking hard evidence that 
IONM can diminish prevalence of permanent vocal fold’s 
palsy as many as 95.7% of the respondents of the most 
recent international survey on the identification and neural 
monitoring of the EBSLN during thyroidectomy expressed 
their confidence in IONM and listed reoperative thyroid 
cases as the top indication far ahead all other clinical 
situations for utilization of this technique during thyroid 
surgery (58).
The introduction of continuous neuromonitoring could 
also represent a promising innovation in redo surgery. 
In the available literature we did not find any analysis of 
the cost-effectiveness of routine use of IONM in thyroid 
reoperations, and this topic should be clarified as well.
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